These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22026961)

  • 1. What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association.
    Vilhelmsson A; Svensson T; Meeuwisse A; Carlsten A
    BMC Clin Pharmacol; 2011 Oct; 11():16. PubMed ID: 22026961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiences from consumer reports on psychiatric adverse drug reactions with antidepressant medication: a qualitative study of reports to a consumer association.
    Vilhelmsson A; Svensson T; Meeuwisse A; Carlsten A
    BMC Pharmacol Toxicol; 2012 Dec; 13():19. PubMed ID: 23259410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
    Matos C; van Hunsel F; Joaquim J
    Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France.
    Montastruc F; Sommet A; Bondon-Guitton E; Durrieu G; Bui E; Bagheri H; Lapeyre-Mestre M; Schmitt L; Montastruc JL
    Eur J Clin Pharmacol; 2012 May; 68(5):767-75. PubMed ID: 22116460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems.
    Härmark L; van Hunsel F; Grundmark B
    Drug Saf; 2015 Apr; 38(4):337-47. PubMed ID: 25627832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.
    Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E
    Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006.
    Aagaard L; Nielsen LH; Hansen EH
    Drug Saf; 2009; 32(11):1067-74. PubMed ID: 19810778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database.
    Gastaldon C; Schoretsanitis G; Arzenton E; Raschi E; Papola D; Ostuzzi G; Moretti U; Seifritz E; Kane JM; Trifirò G; Barbui C
    Drug Saf; 2022 Dec; 45(12):1539-1549. PubMed ID: 36400895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Hyponatraemia and Antidepressant Drugs: A Pharmacovigilance-Pharmacodynamic Assessment Through an Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
    Mazhar F; Pozzi M; Gentili M; Scatigna M; Clementi E; Radice S; Carnovale C
    CNS Drugs; 2019 Jun; 33(6):581-592. PubMed ID: 30977109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
    Durrieu G; Palmaro A; Pourcel L; Caillet C; Faucher A; Jacquet A; Ouaret S; Perault-Pochat MC; Kreft-Jais C; Castot A; Lapeyre-Mestre M; Montastruc JL;
    Drug Saf; 2012 Oct; 35(10):845-54. PubMed ID: 22967189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review.
    Fossouo Tagne J; Yakob RA; Dang TH; Mcdonald R; Wickramasinghe N
    JMIR Public Health Surveill; 2023 Jan; 9():e40080. PubMed ID: 36645706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective observational study to evaluate safety reporting of antidepressants at a tertiary care hospital in India.
    Lucca JM; Madhan R; Gurumurthy P; Dushad R
    Indian J Pharmacol; 2014; 46(5):543-6. PubMed ID: 25298586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses' reporting.
    Karlsson SA; Jacobsson I; Boman MD; Hakkarainen KM; Lövborg H; Hägg S; Jönsson AK
    Eur J Clin Pharmacol; 2015 May; 71(5):631-6. PubMed ID: 25845655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions reported by consumers for nervous system medications in Europe 2007 to 2011.
    Aagaard L; Hansen EH
    BMC Pharmacol Toxicol; 2013 Jun; 14():30. PubMed ID: 23763896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®.
    Svendsen K; Wood M; Olsson E; Nordeng H
    Eur J Clin Pharmacol; 2018 May; 74(5):627-636. PubMed ID: 29290074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A patient-centred web-based adverse drug reaction reporting system identifies not yet labelled potential safety issues.
    Hasford J; Bruchmann F; Lutz M; Thürmann P; Schmiedl S
    Eur J Clin Pharmacol; 2021 Nov; 77(11):1697-1704. PubMed ID: 34143228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse Drug Reactions Spontaneously Reported at a Tertiary Care Hospital and Preventable Measures Implemented.
    Abu Esba LC; Al Mardawi G; AlJasser MI; Aljohani B; Abu Alburak A
    J Clin Pharm Ther; 2021 Apr; 46(2):460-469. PubMed ID: 33285001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reaction reporting by patients in the Netherlands: three years of experience.
    de Langen J; van Hunsel F; Passier A; de Jong-van den Berg L; van Grootheest K
    Drug Saf; 2008; 31(6):515-24. PubMed ID: 18484785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.